Fierce Pharma

NOVEMBER 13, 2023

Novo Nordisk has made a splash with its GLP-1 drugs that have allowed patients to achieve significant weight loss. | Novo Nordisk has made a splash with its GLP-1 drugs that have allowed patients to achieve significant weight loss. Now the Danish company appears on the verge of another breakthrough, showing that the use of its obesity treatment Wegovy can reduce the risk of heart attack.

Patients 250

Patients 250

MedCity News

NOVEMBER 13, 2023

Just 37% of employees trust their insurer to suggest high-quality care regardless of cost, while 53% trust their employer with their health, according to a survey released by Included Health.

Insurance 119

Insurance 119

Fierce Pharma

NOVEMBER 13, 2023

Six months on, Teva’s new “pivot to growth” strategy appears to be paying off. | In 2023’s third quarter, the Israeli-American generics giant reported global sales of $3.9 billion, up 7% from the same period in 2022. The company credited that growth to the strong momentum behind its branded meds Austedo and Ajovy, plus a “stable and sustainable generics business” in the U.S. that’s also seen “continued growth” in Europe and other international markets.

Sales 238

Sales Marketing 238

MedCity News

NOVEMBER 13, 2023

New KFF focus groups revealed that some thought the process of renewing Medicaid coverage during the unwinding of the continuous enrollment provision was simple. Others, however, faced challenges with communication from state Medicaid agencies, and some weren’t aware their coverage had been terminated.

114

114

Advertisement

Distribution

Fierce Pharma

NOVEMBER 13, 2023

To fuel CEO Richard Francis’s “pivot to growth” plan, Teva has turned to royalty financing to fuel the accelerated development of a pipeline antipsychotic drug in its innovation portfolio. | To fuel CEO Richard Francis’s “pivot to growth” plan, Teva has turned to royalty financing to fuel the accelerated development of a long-acting antipsychotic drug.

141

141

MedCity News

NOVEMBER 13, 2023

It’s easy to oversimplify and say, “These big tech companies are now doing healthcare and they’re going to solve everything.” But the reality is that often, the solutions are not going to come from big tech.

Specialization 113

Specialization Healthcare Healthcare 113

MedCity News

NOVEMBER 13, 2023

Novartis gains global rights to Legend Biotech cell therapies that address DLL3, a promising target for lung cancers and other types of solid tumors. The pharmaceutical giant may make these therapies using T-Charge, its next-generation CAR T-cell therapy manufacturing technology.

Manufacturing 110

Manufacturing Pharmaceutical Biopharma Pharma 110

PharmaVoice

NOVEMBER 13, 2023

The arsenal against the world’s deadliest creature is growing and a universal vaccine is in the works.

Pharma 116

Pharma 116

MedCity News

NOVEMBER 13, 2023

A significant healthcare crisis looms as Baby Boomers age, which will contribute to a rise in Alzheimer’s cases. Combined with a shortage of geriatricians and caregivers, we will soon have more lonely seniors in America. We must open our minds to new solutions, such as robotic companions.

Patients 110

Patients Healthcare Healthcare 110

European Pharmaceutical Review

NOVEMBER 13, 2023

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion for GSK’s momelotinib, recommending marketing approval. The Committee deemed it beneficial as a treatment for disease-related splenomegaly (enlarged spleen) or symptoms in adults with moderate to severe anaemia who have primary myelofibrosis, post polycythaemia vera myelofibrosis or post essential thrombocythaemia myelofibrosis and who are Janus kinase (JAK) inhibitor n

Safety 87

Safety Medicine Pharmaceutical Patients 87

Advertisement

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

Safety

MedCity News

NOVEMBER 13, 2023

Ajinomoto’s Forge Biologics acquisition brings contract development and manufacturing organization capabilities in gene therapy. Forge specializes in manufacturing AAV vectors used to deliver these therapies.

Specialization 106

Specialization Manufacturing Biopharma Pharma 106

PharmExec

NOVEMBER 13, 2023

The growing issue of medical debt has caused stakeholders to reevaluate tactics as the cost of pharmaceutical healthcare continues to rise.

Medical 98

Medical Healthcare Healthcare Pharmaceutical 98

MedCity News

NOVEMBER 13, 2023

We are on the edge of rapid innovation in psychiatry. Now is the time to break out of our silos and take advantage of the promise the future holds.

Physicians 113

Physicians FDA Biopharma 113

Pharmaceutical Technology

NOVEMBER 13, 2023

The UK government has announced £267m ($326.4m) funds for developing treatments for drug and alcohol misuse.

Government 95

Government 95

Advertisement

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud

Distribution

MedCity News

NOVEMBER 13, 2023

OmniLife Health’s initial focus with its complex care coordination platform is organ transplant care.

Physicians 107

Physicians 107

Pharmaceutical Technology

NOVEMBER 13, 2023

At the BIO-Europe conference, experts discussed remaining challenges in AI healthcare interventions.

Pharma 98

Pharma Healthcare Healthcare 98

PharmExec

NOVEMBER 13, 2023

Closing the gender gap in pharma—and how we get there together.

Healthcare 111

Healthcare Healthcare Pharma 111

MedTechVets

NOVEMBER 13, 2023

NOV 14th – We were proud to interview and welcome new MedTechVets Board Member, Jeanne Miller. She is the Area Vice President of Sales for Biosense Webster , a division of Johnson & Johnson MedTech and a proud wife and mother of four. Jeanne began her service in the U.S. Marine Corps as an Aviation Supply Officer after graduating from the United States Naval Academy.

Medical 64

Medical Sales Specialization Recruitment 64

Advertisement

Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.

Safety

pharmaphorum

NOVEMBER 13, 2023

Victoria Atkins replaces Barclay as UK health secretary Phil.

108

108

Copyright Clearance Center

NOVEMBER 13, 2023

The post Digital Hollywood Focus on AI and Copyright appeared first on Copyright Clearance Center.

89

89

PharmaTimes

NOVEMBER 13, 2023

Antimicrobial resistance is considered one of the top ten global public health threats - News - PharmaTimes

81

81

pharmaphorum

NOVEMBER 13, 2023

UCB on course for approval of gMG drug Rystiggo in EU Phil.

91

91

Advertisement

When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.

Specialization

PharmaTimes

NOVEMBER 13, 2023

The trial is evaluating an investigational cancer vaccine in combination with Keytruda - News - PharmaTimes

Patients 80

Patients 80

PharmExec

NOVEMBER 13, 2023

MilliporeSigma’s Stephen Wing, head of Analytical and Logistical Services, discusses the ways in which digital transformation and data transparency dramatically enhance supply chains, and how manufacturers are using the company’s eMERGE™ platform to improve overall efficiencies.

Manufacturing 52

Manufacturing 52

PharmaTech

NOVEMBER 13, 2023

In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.

Pharma 52

Pharma Pharmaceutical 52

PharmExec

NOVEMBER 13, 2023

FDA expands indications for bupivacaine liposome injectable suspension (Exparel; Pacira BioSciences, Inc.) for use in adult patients as an adductor canal block and a sciatic nerve block in the popliteal fossa.

FDA 40

FDA Patients 40

Advertisement

Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic

Leads

Pharmaceutical Technology

NOVEMBER 13, 2023

On 8 November, Takeda announced it had received US Food and Drug Administration (FDA) approval for its oral Fruzaqla (fruquintinib) as a third-line treatment for adults with metastatic colorectal cancer (mCRC).

Food and Drug Administration 52

Food and Drug Administration FDA Food 52

Clarivate

NOVEMBER 13, 2023

Clinical outcome assessments can take years to generate but may pay big dividends in patient-focused drug development, centering the patient experience and potentially bolstering a product’s case with regulators and payers. The global Clarivate clinical outcome assessment team is comprised of health psychologists and outcomes researchers who have extensive methodological and commercial experience.

Patients 52

Patients Food and Drug Administration FDA Safety 52

pharmaphorum

NOVEMBER 13, 2023

Akili says OTC switch for ADHD DTx leads to sales rise Phil.

Leads 88

Leads Sales 88

Pharmaceutical Technology

NOVEMBER 13, 2023

The EMA CHMP provided a positive opinion for granting approval to Merck’s Keytruda combination therapy to treat biliary tract cancer.

59

59

Advertisement

As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.

Management